Companies
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
European Biotech Sector Growing Quicker Than US Counterpart
January 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Growth of the global biotechnology sector is expected to exceed that of the pharmaceutical industry significantly over the next five years. Currently, 83% and of pharmaceutical sales are from small-molecules and 15% from biologicals. But, by 2010, only 76% of sales will be from small-molecules and 22% from biologicals. At that time, the global biotechnology market will be worth just over US$100bn - a 70% increase on 2005 sales